ClinVar Miner

Submissions for variant NM_014244.5(ADAMTS2):c.3195C>T (p.Gly1065=)

gnomAD frequency: 0.00034  dbSNP: rs778572930
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001241752 SCV001414793 likely benign Ehlers-Danlos syndrome, dermatosparaxis type 2024-01-18 criteria provided, single submitter clinical testing
Mayo Clinic Laboratories, Mayo Clinic RCV001357030 SCV001713348 uncertain significance not provided 2020-11-13 criteria provided, single submitter clinical testing
GeneDx RCV001357030 SCV001826065 likely benign not provided 2020-03-25 criteria provided, single submitter clinical testing
Department of Pathology and Laboratory Medicine, Sinai Health System RCV001357030 SCV001552355 uncertain significance not provided no assertion criteria provided clinical testing The ADAMTS2 p.Gly1065Gly variant was not identified in the literature nor was it identified in ClinVar or LOVD 3.0. The variant was identified in dbSNP (ID: rs778572930) and in control databases in 26 of 282238 chromosomes at a frequency of 0.00009212 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: Latino in 14 of 35350 chromosomes (freq: 0.000396), African in 8 of 24922 chromosomes (freq: 0.000321), South Asian in 1 of 30556 chromosomes (freq: 0.000033) and European (non-Finnish) in 3 of 128808 chromosomes (freq: 0.000023), but was not observed in the Ashkenazi Jewish, East Asian, European (Finnish), or Other populations. The p.Gly1065Gly variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. However, three of four in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predict a great than 10% difference in splicing and the creation of a new 5' splice site. However, this has not been confirmed by RNA analysis and is not predictive enough to assume pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.